Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Pulsed electric field treatment may help shrink untreated liver tumors.

A new finasteride treatment may quickly and effectively promote hair regrowth.

More frequent PRP sessions with shorter intervals improve hair loss treatment.

Candida antigen is an effective and promising treatment for alopecia areata.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Liposomal IGF-1 safely and effectively treats hair loss in hamsters.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

A new method effectively predicts estrogen-related health effects for early screening.

High TNF-α levels may increase hair loss risk after PRP therapy.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

PRP injections may be an effective treatment for severe hair loss.

Six African American women experienced hair loss after switching to a new HIV medication.